D-dimer testing in clinical practice in the era of COVID-19.

Auditeau, Claire; Khider, Lina; Planquette, Benjamin; Sanchez, Olivier; Smadja, David M; Gendron, Nicolas

Auditeau, Claire; Khider, Lina; Planquette, Benjamin; Sanchez, Olivier; Smadja, David M; Gendron, Nicolas.

Afiliação

Auditeau C; Hematology Department Assistance Publique Hôpitaux de Paris-Centre Université de Paris (APHP-CUP) Paris France.
Khider L; Université Paris Cité Innovative Therapies in Haemostasis INSERM Paris France.
Planquette B; Biosurgical Research Lab (Carpentier Foundation) Assistance Publique Hôpitaux de Paris-Centre Université de Paris (APHP-CUP) Paris France.
Sanchez O; Vascular Medicine Department Assistance Publique Hôpitaux de Paris-Centre Université de Paris (APHP-CUP) Paris France.
Smadja DM; Université Paris Cité Innovative Therapies in Haemostasis INSERM Paris France.
Gendron N; Biosurgical Research Lab (Carpentier Foundation) Assistance Publique Hôpitaux de Paris-Centre Université de Paris (APHP-CUP) Paris France.

Res Pract Thromb Haemost ; 6(4): e12730, 2022 May.

Article em En | MEDLINE | ID: mdl-35664536

Palavras-chave

COVID19; COVID19 vaccines; Ddimer; anticoagulant; biomarker; disseminated intravascular coagulation; fibrin; fibrin fragment D; fibrinogen degradation products; predictive value of tests; prognosis; pulmonary embolism; venous thromboembolism

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google